KLK3 and prostate cancer: Fourthly, we investigated whether a greater improvement in identifying high (vs low) risk prostate cancers could be achieved by including both genetic correction of PSA levels and the combined effect of risk variants thought to be associated with aggressive (vs indolent) prostate cancer.